Skip to main content
Industry News
SARS-CoV-2 vaccine for cats in the works

EvviVax, a unit of Italy-based Takis Biotech, and New York-based Applied DNA Sciences are collaborating on a feline vaccine for SARS-CoV-2 that is based on Takis' COVID-19 vaccine. Though SARS-CoV-2 infections have been confirmed in only 54 domestic cats in the US, Takis CEO Luigi Aurisicchio says vaccinating cats will prevent virus mutations that could be dangerous to people and pets.

Full Story: